Dare Bioscience, Inc.
Publicly observedSan Diego, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Diego | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Dare Bioscience, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | UC4EFLZHANH4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant17 Dec 2024Publicly observed
NIH SBIR/STTR award: A first-in-class product for the clearance of high-risk human papillomaviruses
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant17 Dec 2024Publicly observed
NIH SBIR/STTR award: A first-in-class product for the clearance of high-risk human papillomaviruses
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant12 Dec 2023Publicly observed
NIH SBIR/STTR award: A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women
USD 1,016,258.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant1 Aug 2023Publicly observed
NIH SBIR/STTR award: Therapeutic targeting of FKBP51 for the prevention of stress-induced preterm birth
USD 907,702.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.